Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

The invention relates to a cosmetic process for caring for or making up keratin materials, comprising the topical application to the keratin materials of a cosmetic composition comprising a phosphonic polymer derived from the polymerization of: (a) 45% to 95% by weight of ethylenic monomer bearing an at least C.sub.8 linear or branched alkyl group; (b) 5% to 25% by weight of vinylphosphonic acid monomer; (c) 0 to 50% by weight of additional monomer chosen from linear or branched C.sub.1C.sub.6 alkyl (meth)acrylates, C.sub.6-C.sub.12 cycloalkyl (meth)acrylates, and polydimethylsiloxanes bearing a mono(meth)acryloyloxy end group, optionally combined with an additional compound chosen from polyamine compounds bearing several primary amine and/or secondary amine groups, aminosilanes, salts of divalent or trivalent metal ions, clays and metal oxides. The process makes it possible to obtain a film-forming deposit that has good resistance to water, to oil and to sebum. The film is also non-tacky and transfer-resistant. The invention also relates to polymers containing the three monomers (a), (b) and (c).

The invention relates to a cosmetic process for caring for or making up keratin materials, comprising the topical application to the keratin materials of a cosmetic composition comprising a phosphonic polymer derived from the polymerization of: (a) 45% to 95% by weight of ethylenic monomer bearing an at least C.sub.8 linear or branched alkyl group; (b) 5% to 25% by weight of vinylphosphonic acid monomer; (c) 0 to 50% by weight of additional monomer chosen from linear or branched C.sub.1C.sub.6 alkyl (meth)acrylates, C.sub.6-C.sub.12 cycloalkyl (meth)acrylates, and polydimethylsiloxanes bearing a mono(meth)acryloyloxy end group, optionally combined with an additional compound chosen from polyamine compounds bearing several primary amine and/or secondary amine groups, aminosilanes, salts of divalent or trivalent metal ions, clays and metal oxides. The process makes it possible to obtain a film-forming deposit that has good resistance to water, to oil and to sebum. The film is also non-tacky and transfer-resistant. The invention also relates to polymers containing the three monomers (a), (b) and (c).

The present invention relates to red effect pigments including a nonmetallic substrate in platelet form and a coating applied thereto, wherein the coating includes at least one of metal oxide, metal hydroxide or metal oxide hydrate, the metal ions of the metal oxide, metal hydroxide and/or metal oxide hydrate comprise at least two different metal ions selected from the group of metals consisting of Fe, Sn, Ti and Zr, and to a process for production thereof and to the use of the red effect pigments.

The present invention relates to red effect pigments including a nonmetallic substrate in platelet form and a coating applied thereto, wherein the coating includes at least one of metal oxide, metal hydroxide or metal oxide hydrate, the metal ions of the metal oxide, metal hydroxide and/or metal oxide hydrate comprise at least two different metal ions selected from the group of metals consisting of Fe, Sn, Ti and Zr, and to a process for production thereof and to the use of the red effect pigments.

It relates to an anhydrous composition for caring for and/or making up keratin materials comprising, a) 10%˜40% by weight of at least one non-volatile non-phenyl silicone oil, relative to the total weight of the composition; b) at least one non-volatile hydrocarbon-based oil and/or phenyl silicone oil; c) at least one high viscosity ester; and d) reaction product of an unsaturated-functional silicone resin, an Si—H functional organopolysiloxane crosslinker bearing pendant hydrido functionality and optionally, an unsaturated hydrocarbon having four or more carbon atoms, in a low viscosity organopolysiloxane. It relates to a process for caring for and/or making up keratin materials such as the skin and the lips, preferably the lips, by applying the anhydrous composition according to the present invention to the keratin materials.

It relates to an anhydrous composition for caring for and/or making up keratin materials comprising, a) 10%˜40% by weight of at least one non-volatile non-phenyl silicone oil, relative to the total weight of the composition; b) at least one non-volatile hydrocarbon-based oil and/or phenyl silicone oil; c) at least one high viscosity ester; and d) reaction product of an unsaturated-functional silicone resin, an Si—H functional organopolysiloxane crosslinker bearing pendant hydrido functionality and optionally, an unsaturated hydrocarbon having four or more carbon atoms, in a low viscosity organopolysiloxane. It relates to a process for caring for and/or making up keratin materials such as the skin and the lips, preferably the lips, by applying the anhydrous composition according to the present invention to the keratin materials.

The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.

The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.